Core Capital Management & Research, inc.’s Sabra Healthcare REIT SBRA Stock Holding History

Core Capital Management & Research, inc.’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+10,000	New	+$198K	0.11%	85

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Core Capital Management & Research, inc.'s SBRA Position: Q2 2026 in Review

Core Capital Management & Research, inc. opened a new position in Sabra Healthcare REIT (SBRA) in Q2 2026: 10,000 shares worth $204K. The stake represents 0.11% of the portfolio and ranks #85 among its holdings.

464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Core Capital Management & Research, inc. held 10,000 shares of Sabra Healthcare REIT worth $204K as of Q2 2026.
Sabra Healthcare REIT was a new Core Capital Management & Research, inc. position in Q2 2026.
Sabra Healthcare REIT made up 0.11% of Core Capital Management & Research, inc.'s portfolio in Q2 2026, its #85 holding.
464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Core Capital Management & Research, inc.'s 13F filing for Q2 2026, filed 9 Sep 2026.